World’s largest healthcare group lifts guidance despite litigation worries

Opioid maker sought drug group that treats abuse of its own painkillers

False rumours and anti-government sentiment spur resurgence of infectious disease

US group seeks regulatory approval for first ‘game-changing’ product in two decades

Consumer goods giant sheds £3bn in market value over potential exposure to opioid charges

UK-listed drugmaker vows to contest allegations as shares fall more than 70%

Republican and Democratic senators accuse industry intermediaries of harming consumers

Rapid growth at start-up 10x Genomics led to a rethink of how to manage a team

Company reveals partnerships and data protection compliance for voice-activated device

Biotech group says billionaire investor bought a treatment to prevent competition

Moves on painkillers, antidepressants and schizophrenia meds defy political pressure

Purdue Pharma owners file motion to dismiss lawsuit from Massachusetts attorney-general

Drug companies bet technology can revolutionise the $65bn market for clinical trials

Activist investor Starboard ends proxy fight after ISS and Glass Lewis support takeover

State files ‘nation’s most extensive lawsuit’ against a raft of drugmakers and distributors

The tech giant’s ‘growth team’ brought it over a billion users – but did it also sow the seeds for current troubles?

Deal with Oklahoma by Purdue Pharma and Sackler family owners could be first of many

Biogen’s aducanumab was last hope of one approach to the disease, but there are others

Drugmaker loses $18bn from market value after deciding to discontinue trials

Developers of Crispr technique for genome editing also call for halt to experiments on hereditary genes

Purdue Pharma says FDA will expedite approval process for its not-for-profit injection

Tobacco stocks move lower on fears regulator’s tough push against ecigarettes will continue

Group reveals more details about company created with Berkshire Hathaway and JPMorgan

Johnson & Johnson given green light to sell a nasal spray based on ketamine